Department of Health and Human Services Public Health Service

First Page		Document Content
Medicine 5-HT3 antagonist Ondansetron Chemotherapy-induced nausea and vomiting Granisetron Dolasetron Palonosetron Serotonin Mirtazapine Chemistry Antiemetics Organic chemistry		Department of Health and Human Services Public Health Service Add to Reading List Source URL: www.fda.gov Download Document from Source Website File Size: 116,54 KB Share Document on Facebook

	p e e r r e vi e w e d Physical and Chemical Stability of Palonosetron with Metoclopramide and Promethazine During Simulated DocID: 1vpOY - View Document
	IJPC peer reviewed Physical and Chemical Stability of Palonosetron Hydrochloride with Glycopyrrolate and Neostigmine DocID: 1voqL - View Document
	Akynzeo, INN-netupitant & palonosetron hydrochloride DocID: 1s0tC - View Document
	HELSINN GROUP SIGNS EXCLUSIVE AGREEMENT WITH PURDUE PHARMA CANADA FOR THE DISTRIBUTION AND LICENSING RIGHTS OF AKYNZEO® (NETUPITANT/PALONOSETRON combo) IN CANADA Lugano, SWITZERLAND and Pickering, CANADA, April 25, 2016 DocID: 1mNEH - View Document
	26 March 2015 EMA/CHMPCommittee for Medicinal Products for Human Use (CHMP) Summary of opinion 1 (initial authorisation) DocID: 16ga6 - View Document